Multiple Hepatic Receptors Cooperate to Eliminate Secretory Mucins Aberrantly Entering the Bloodstream: Are Circulating Cancer Mucins the “Tip of the Iceberg”?
Published version of a preprint
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Hollow organs lined by columnar epithelial cells normally secrete mucins and their proteolytic fragments vectorially into the lumen. These heterogeneously O-glycosylated molecules are known to aberrantly enter the bloodstream in the setting of epithelial carcinomas and possibly during injury or inflammation. We have recently shown that carcinoma mucin fragments can trigger the rapid formation of platelet-rich microthrombi in vivo. Thus, mechanisms to clear such aberrantly secreted mucins must exist. Indeed, we found that i.v. injected carcinoma mucin fragments had an ∼1 minute half-life in mice, which was primarily due to rapid clearance by hepatic reticuloendothelial cells. Inhibition of known glycan-recognizing hepatic clearance receptors showed involvement of multiple partially overlapping clearance systems. Studies of genetically deficient mice and incomplete competition between different mucins confirmed this result. Thus, multiple hepatic clearance receptors cooperate to eliminate secretory mucins entering the circulation, limiting potential pathology. This may also explain why mucin-type clustered O-glycosylation is rare on plasma proteins. Notably, small subsets of injected carcinoma mucins remained unrecognized by clearance systems, had a much longer half-life, and carried highly sialylated O-glycans. Similar circulating mucins were found in tumor-bearing mice despite lack of saturation of hepatic clearance mechanisms. Thus, circulating cancer mucins currently used as clinical diagnostic markers likely represent only the clearance-resistant “tip of the iceberg.” Such aberrantly circulating mucins could play pathologic roles not only in cancer but also during injury or inflammation of hollow organs and in liver disease. (Cancer Res 2006; 66(4): 2433-41)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, extended segments of some mucins are even resistant to broad-spectrum proteases like proteinase K (511 -512).”
From Biological roles of glycans (2017) · cites this paper as [512]
In the citing paper
“There also appears to be a very high-capacity system for clearance of incompletely glycosylated mucins by the liver (512).”
From Biological roles of glycans (2017) · cites this paper as [512]
Citations
Cites
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807 · cited 3×
“cancers (4, 5, 11, 24), a feature that has been termed ‘‘glycody-”
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304146101 · Cited by 1,292
Krieger, M., & Krieger, J. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.003125 · Cited by 1,160 · cited 2×
“, including SR-BI) suggests that SR-BI contributes f9% (59).”
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils
Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P., & Krieger, M. (1990) · Nature · doi:10.1038/343531a0 · Cited by 1,041
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori, S. (1996) · PubMed · Cited by 987
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714
Self-citationHuman uptake and incorporation of an immunogenic nonhuman dietary sialic acid
Tangvoranuntakul, P., Gagneux, P., Diaz, S., Bardor, M., Varki, N., Varki, A., & Muchmore, E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2131556100 · Cited by 625
Self-citationBinding of L-Selectin to the Vascular Sialomucin CD34
Baumheter, S., Singer, M. S., Henzel, W., Hemmerich, S., Renz, M., Rosen, S. D., & Lasky, L. A. (1993) · Science · doi:10.1126/science.7692600 · Cited by 619
L-selectin-mediated lymphocyte rolling on MAdCAM-1
Berg, E. L., McEvoy, L. M., Berlin, C., Bargatze, R. F., & Butcher, E. C. (1993) · Nature · doi:10.1038/366695a0 · Cited by 536 · cited 1×
“ASF 14 78 20 (13-27) GalNAca-O-Me 14 79 20 (19-20)”
Research works printed but not linked: 1
- Moore E, Soper D. Clinical utility of CA125 levels in predicting laparoscopically confirmed salpingitis in patients with clinically diagnosed pelvic inflammatory disease. Infect Dis Obstet Gynecol 1998; 6: 182–5. · doi:10.1002/(sici)1098-0997(1998)6:4<182::aid-idog8>3.0.co;2-t
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“There also appears to be a very high-capacity system for clearance of incompletely glycosylated mucins by the liver (512).”
BackgroundSelf-citationSialic acids in human health and disease
Varki, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.002 · Cited by 999
“The sialylated forms of these mucins are resistant to clearance by liver receptors [111], which is likely to explain the association of unusual thrombotic events with mucin-producing carcinomas – called Trousseau’s syndrome [112,113].”
Self-citationTrousseau's syndrome: multiple definitions and multiple mechanisms
Varki, A. (2007) · Blood · doi:10.1182/blood-2006-10-053736 · Cited by 840
Self-citationMUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
Felder, M., Kapur, A., Gonzalez-Bosquet, J., Horibata, S., Heintz, J., Albrecht, R., Fass, L., Kaur, J., Hu, K., Shojaei, H., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-129 · Cited by 524
“Mucins in systemic circulation are rapidly processed by the reticulo-endothelial cells, leaving behind only a fraction of the mucins in circulation to be detected in clinical assays such as the CA125 test [89].”
BackgroundThe Ashwell receptor mitigates the lethal coagulopathy of sepsis
Grewal, P. K., Uchiyama, S., Ditto, D., Varki, N., Le, D. T., Nizet, V., & Marth, J. D. (2008) · Nature Medicine · doi:10.1038/nm1760 · Cited by 374
“Localized to the vascular face of the hepatocyte cell surface, the Ashwell receptor is positioned to remove and degrade potentially deleterious circulating glycoprotein”
Background
Metadata
- Authors
- Wahrenbrock, M. G., & Varki, A.
- Affiliations
- University of California San Diego (US)
- ORCID
- Varki, Ajit
- Venue
- Cancer Research
- Published
- 2006-02-15
- Volume
- 66
- Issue
- 4
- Pages
- 2433-2441
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2131813152
- Cited by
- 58
- References
- 78
- Citations by year
- 2025: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01 CA 38701, R01CA038701)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- secretory mucins, hepatic clearance, reticuloendothelial cells, O-glycosylation, circulating tumor markers, epithelial cancers, liver disease
- MeSH terms
- Adenocarcinoma, Animals, Colonic Neoplasms, Humans, Liver, Mice, Inbred C57BL, Mucins, Polysaccharides, Receptors, Cell Surface, Mononuclear Phagocyte System, Hyaluronan Receptors, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Mannose-Binding Lectins, Cell Line, Tumor, Receptors, Scavenger, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multiple Hepatic Receptors Cooperate to Eliminate Secretory Mucins Aberrantly Entering the Bloodstream: Are Circulating Cancer Mucins the “Tip of the Iceberg”? https://app.cochat.ai/papers/10.1158/0008-5472.can-05-3851
- The paper
- Wahrenbrock, M. G., & Varki, A. (2006). Multiple Hepatic Receptors Cooperate to Eliminate Secretory Mucins Aberrantly Entering the Bloodstream: Are Circulating Cancer Mucins the “Tip of the Iceberg”? Cancer Research. https://doi.org/10.1158/0008-5472.can-05-3851
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.